Wednesday, 18 September 2019

Japan News

  • FDA slams Shionogi for eyeing profit over patient safety

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 May, 2013

    Singapore: The FDA had during September 2012 informed Shionogi that it need to conduct two clinical trials in order to evaluate the risk of irregular heartbeat associated with its Rybix pai...Read more

  • Medical laser market to reach $8.8 bn by 2018: GIA

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

    Singapore: Technological advancements in laser technology have created a plethora of applications in the medical field, leading to significant rise in the number of procedures carried out u...Read more

  • Chugai, Nippon Shinyaku tie up for drug development

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

    Singapore: Tokyo-headquartered Chugai Pharmaceutical and Kyotobased Nippon Shinyaku have entered into an agreement to co-develop and co-market GA101 (obinutuzumab), the first glycoengineere...Read more

  • INC Research opens two new offices in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Singapore: INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, announced the establishment of INC ...Read more

  • Deregulation will boost Japanese pharma sector

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Singapore: Japan's pharmaceutical industry is the second largest in the world, worth $89 billion in 2011 or 10 percent of the world market. The industry grew from $62.8 billion in 2005 to i...Read more

  • Takeda gets FDA nod for three diabetes drugs

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2013

    Singapore: Japan-headquartered Takeda Pharmaceutical received the US Food and Drug Administration (FDA) approval for Nesina (alogliptin) and the fixed-dose combination (FDC) therapies Oseni...Read more

  • Teva appoints new chairman for Japan, South Korea

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

    Singapore: Teva Pharmaceutical has appointed Professor Itzhak Krinsky as chairman of Teva Japan and Teva South Korea and head of Business Development Asia-Pacific. Currently serving as exec...Read more

  • Germany seeks closer partnership with Japan in biopharma

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 09 Oct, 2012

    Singapore: Germany Trade & Invest and the Health-Made in Germany initiative will join forces at this year's BioJapan 2012 from October 10-12. Representatives from German and Japanese bi...Read more

  • Interphex Japan: Japan pharma eyes China, India

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

    Tokyo: The 7th in-Pharma Japan and 26th Interphex Japan, which are being concurrently held at Tokyo Big Sight, Japan, kick started with much pomp and grandeur. The keynote address, which f...Read more

  • Daiichi may take legal action against ex-Ranbaxy promoters

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 May, 2013

    Singapore: Breaking its silence for the first time in 10 days after Indian drug major Ranbaxy's $500 million settlement of the US Food and Drug Administration (FDA) felony charges over drug...Read more

  • Free software creates largest neural simulation

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    Singapore: Researchers from the Riken HPCI Program for Computational Life Sciences, the Okinawa Institute of Technology Graduate University in Japan and Forschungszentrum Jülich in Germ...Read more

  • Seegene and Eidia to bring MoDx tests to Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2013

    Singapore: Seegene, a leading developer of multiplexed molecular technologies and diagnostic tests, has entered into a collaboration agreement with Eidia, the in vitro diagnostics subsidiar...Read more

  • Reverse Medical announces alliance in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    Singapore: Reverse Medical announced entering into a strategic partnership agreement with Century Medical (CMI), for distribution of the Reverse Medical products in Japan. CMI, a subsidiary...Read more

  • FDA accepts Astellas' NDA for organ rejection drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Dec, 2012

    Singapore: Astellas Pharma, US, a US subsidiary of Tokyo-based Astellas Pharma, received US FDA acceptance for review of the company's New Drug Application (NDA) for tacrolimus extended re...Read more

  • Dainippon, Nippon Shinyaku sign deal for new drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: Dainippon Sumitomo Pharma (DSP), headquartered in Japan, and Nippon Shinyaku, also a Japanese company, have concluded a license agreement for exclusive rights to develop, manufac...Read more

  • Takeda drug Azilva launched in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 29 May, 2012

    Singapore: Takeda Pharmaceutical's Azilva (azilsartan) is now available for the treatment of hypertension in Japan. Discovered by Takeda, azilsartan is an angiotensin II receptor blocker (A...Read more

  • Japan approves Humira for Crohn's disease patients

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2012

    Singapore: Japan's Ministry of Health, Labor and Welfare has approved the use of Humira in induction and maintenance of clinical remission in patients with moderately to severely active Cro...Read more

  • Takeda asks judge to rule in its favor

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Apr, 2013

    Singapore: Takeda Pharmaceuticals, US, highlighted that in the case against Jack Cooper (No CGC-12-518535) the jury ruled in favor of the plaintiffs and awarded a total of $6.5 million in d...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls